引導式測驗 · 中等 等級

AI 胜肽治療設計測驗

測試計算設計與治療證據、結合和功能、穩定性、選擇性和實驗驗證。

相關引導路徑AI 胜肽藥物設計
問題 1 的 8

What does a computationally designed peptide sequence establish?

預覽每個問題8 問題

當您參加測驗時,就會出現答案和解釋。

  1. What does a computationally designed peptide sequence establish?
    • Proof of target engagement in the body
    • A candidate sequence for experimental testing
    • A clinically effective medicine
    • A safe dose for patients
  2. Why test binding with an independent assay?
    • A predicted interface may not reflect actual experimental binding
    • A structural model proves binding already
    • Independent assays replace biological controls
    • Binding results determine clinical efficacy
  3. Does a peptide binder necessarily alter target function?
    • Yes, all binders inhibit targets
    • Yes, docking scores measure function
    • No, peptides cannot bind proteins
    • No; binding alone does not show agonism, inhibition, or therapeutic effect
  4. Which properties should be checked beyond target binding?
    • Only model confidence
    • Only the target’s name
    • Stability, selectivity, delivery, exposure, and toxicity
    • Only sequence length
  5. Why might a peptide fail despite a strong predicted structure?
    • The model tested toxicity already
    • Its experimental conformation or biological stability may differ
    • Predicted structure guarantees in-vivo exposure
    • A flexible target always binds tightly
  6. Which evidence is needed before describing a candidate as a therapy?
    • One in-vitro binding result
    • A generated amino-acid sequence
    • Evidence progresses through functional, safety, pharmacology, and clinical studies
    • A docking score above a threshold
  7. What information supports reproducibility of peptide experiments?
    • Sequence, modifications, target construct, assay conditions, and model version
    • Only the project title
    • Only the lab’s location
    • Only the predicted structure image
  8. What can AI contribute to peptide development?
    • Replace synthesis and safety studies
    • Guarantee delivery to a tissue
    • Confirm patient benefit from binding
    • Prioritize sequences and explore a design space for later testing